Stock listing

BX Swiss:BA3 Azenta, Inc. Aktie

Swiss listing (BX Swiss) of Azenta, Inc. · home listing NASDAQ:AZTA

Follow Azenta, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:AZTA

$44.80 USD -3.89 (-8.0%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:AZTA

Past year +49.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$44.18 – $46.65 USDNov 20, 2026
Volume
621,104 sharesNov 20, 2026
Market cap
$1.96B USDAt the close on Nov 20, 2026 · price × 43.81M shares outstanding
52-week range
$15.93 – $50.06 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$38.31M USDMedian day 853,748 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Azenta, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:AZTA · Home$44.80 USD-3.89 (-8.0%)621,104$45.97$46.65$44.18$48.69Close on Nov 20, 2026
LSE:0HQ1$44.73 USD-4.01 (-8.2%)345$45.19$46.30$44.63$48.74Close on Nov 20, 2026
Frankfurt:BA3€41.20 EUR-3.00 (-6.8%)—€42.40€42.40€41.20€44.20Close on Nov 20, 2026
Munich:BA3€43.20 EUR-1.60 (-3.6%)—€43.20€43.20€43.20€44.80Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:AZTA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$44.80-3.89-8.0%$45.97$46.65$44.18621,104
$48.69+2.88+6.3%$46.24$48.96$45.57695,944
$45.81-1.41-3.0%$47.07$48.12$45.291,412,190
$47.22+1.57+3.4%$44.32$47.40$44.321,330,950
$45.65+1.79+4.1%$44.26$45.68$43.151,114,038
$43.86-5.04-10.3%$46.60$47.00$43.52910,539
$48.90+8.42+20.8%$46.55$50.06$43.672,486,317
$40.48-0.47-1.1%$40.47$40.86$39.70675,893
$40.95+1.79+4.6%$39.77$41.28$39.42733,868
$39.16+1.78+4.8%$37.28$39.34$37.23792,082
$37.38-1.76-4.5%$38.55$38.99$36.981,066,153
$39.14+2.00+5.4%$38.51$39.61$37.66916,363
$37.14+1.59+4.5%$35.66$37.44$35.051,033,469
$35.55-3.51-9.0%$39.18$39.53$35.46957,707
$39.06-2.21-5.4%$39.56$40.35$38.07895,243
$41.27+0.64+1.6%$40.61$41.71$40.46825,685
$40.63+1.55+4.0%$39.06$41.26$39.05900,734
$39.08+1.91+5.1%$37.14$40.27$36.881,676,549
$37.17+0.67+1.8%$36.60$37.33$36.52657,937
$36.50+0.49+1.4%$35.67$36.60$35.21478,678
$36.01-0.75-2.0%$36.66$37.23$35.51813,313
$36.76+1.03+2.9%$35.44$37.10$34.93635,729
$35.73+0.89+2.6%$35.04$36.41$34.51769,853
$34.84+0.75+2.2%$34.55$35.56$34.10791,899
$34.09-2.43-6.7%$36.52$37.37$33.031,262,519
$36.52-0.66-1.8%$36.95$37.11$35.201,217,356
$37.18-0.69-1.8%$37.48$38.92$37.061,112,838
$37.87+0.10+0.3%$37.77$38.40$37.18663,252
$37.77+0.05+0.1%$37.42$37.99$36.571,042,169
$37.72+1.72+4.8%$35.94$38.34$35.881,163,065
$36.00+0.11+0.3%$35.74$36.19$34.931,220,891
$35.89-3.46-8.8%$38.33$39.11$35.561,690,988
$39.35-3.38-7.9%$43.76$46.41$39.332,544,088
$42.73+3.98+10.3%$39.49$43.22$38.842,370,511
$38.75+4.27+12.4%$35.05$42.00$34.663,384,485
$34.48-0.41-1.2%$34.92$35.03$34.19935,976
$34.89+0.61+1.8%$34.37$35.24$34.14929,060
$34.28+0.03+0.1%$34.21$34.45$33.66813,906
$34.25+0.23+0.7%$33.58$34.71$33.28736,977
$34.02-0.18-0.5%$34.36$34.39$33.67781,096
$34.20+0.11+0.3%$33.69$34.82$33.51917,803
$34.09-0.19-0.6%$34.15$34.88$33.88769,257
$34.28+0.53+1.6%$34.00$34.86$33.721,131,872
$33.75+0.51+1.5%$33.53$33.97$33.10718,184
$33.24-0.39-1.2%$33.44$33.82$33.031,430,309
$33.63+0.42+1.3%$33.94$34.04$33.37750,809
$33.21+0.18+0.5%$33.03$33.93$32.98729,672
$33.03+0.99+3.1%$31.93$33.82$31.93718,488
$32.04+1.19+3.9%$30.88$32.28$30.27688,779
$30.85+0.67+2.2%$30.56$31.08$30.18748,607
$30.18+0.03+0.1%$29.74$30.38$29.64853,748
$30.15-0.67-2.2%$30.57$30.72$30.06879,590
$30.82-0.51-1.6%$30.82$31.66$30.661,159,911
$31.33+0.15+0.5%$30.66$31.58$30.61751,929
$31.18-0.55-1.7%$32.26$32.44$30.81758,635
$31.73+0.16+0.5%$31.60$32.19$31.18792,770
$31.57-1.08-3.3%$32.56$33.41$30.571,453,941
$32.65-0.30-0.9%$32.73$33.02$32.27475,580
$32.95-0.66-2.0%$33.61$33.76$32.49659,508
$33.61+0.04+0.1%$33.57$33.94$33.29490,986
$33.57+0.36+1.1%$32.83$33.65$32.45602,532
$33.21+0.33+1.0%$33.06$33.93$32.77988,849
$32.88-4.52-12.1%$33.32$34.31$31.861,895,730
$37.40+0.89+2.4%$36.55$37.49$36.05647,100
$36.51+0.89+2.5%$35.25$37.15$35.14706,922
Ticker
BX Swiss:BA3
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
BX Swiss
Currency
CHF

What changed lately

Latest news

All Azenta, Inc. news

Azenta, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
21 in the last 12 months · 192 in all · newest Nov 17, 2026 · oldest 2019
Calls
20 calls with a replay · 20 with a transcript · latest Nov 11, 2026
Decks
52 decks · latest Nov 11, 2026

Where Azenta, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:AZTA · Home listingNASDAQUnited StatesUSD
LS Exchange:257275LS ExchangeGermanyEUR
Tradegate:BA3TradegateGermanyEUR
gettex:BA3gettexGermanyEUR
LSE:0HQ1LSEUnited KingdomUSD
Lang & Schwarz:257275Lang & SchwarzGermanyEUR
BOATS:AZTABOATSUnited StatesUSD
B3:A2ZT34B3BrazilBRL
Dusseldorf:BA3DusseldorfGermanyEUR
Frankfurt:BA3FrankfurtGermanyEUR
Munich:BA3MunichGermanyEUR
Stuttgart:BA3StuttgartGermanyEUR
BX Swiss:BA3 · This pageBX SwissSwitzerlandCHF

Valuation

EV/sales 2.6× against a median of 6.7×: 3rd lowest of 11 Diagnostics & research services companies shown. Statements: Year to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.63B USD
P/E
Loss
EV/sales
2.6×
EV/EBITDA
Negative EBITDA
Price/book
1.4×
Gross margin
44.2%
Operating margin
−28.1%
Net margin
−26.9%
Debt to equity
0.0×
Beta vs S&P 500
1.59

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Azenta, Inc. · NASDAQ:AZTAUS$1.96BUS$1.63Bn/a2.6×n/a1.4×−26.9%0.0×1.59
Veracyte, Inc. · NASDAQ:VCYTUS$2.03BUS$1.70B16.0×2.9×14.0×1.4×21.8%0.0×1.34
OneSource Specialty Pharma Limited · NSE:ONESOURCEUS$1.99BUS$2.18Bn/a12.0×50.9×3.1×−0.1%0.3×n/a
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Class A · SSE:603456US$1.97BUS$1.77B22.0×2.2×n/a1.5×11.3%0.0×n/a
Syngene International Ltd. · NSE:SYNGENEUS$1.96BUS$1.96B97.5×5.2×20.0×3.7×5.3%0.1×n/a
Cohance Lifesciences Ltd · NSE:COHANCEUS$1.91BUS$1.88B167×8.1×55.1×4.5×5.0%0.1×n/a
Alamar Biosciences, Inc. · NASDAQ:ALMRUS$1.84BUS$1.66Bn/a14.5×n/a6.1×−48.2%0.1×1.70
Fortrea Holdings Inc. · NASDAQ:FTREUS$1.79BUS$2.62Bn/a1.0×28.7×3.4×−2.6%2.0×1.68
ChemoMetec A/S · OMXCOP:CHEMMUS$1.72BUS$1.68B58.0×22.3×40.6×16.1×39.5%0.0×n/a
GemPharmatech Co., Ltd. Class A · SSE:688046US$1.65BUS$1.49B54.4×10.5×n/a4.7×21.5%0.0×n/a
PolyPeptide Group AG · SIX:PPGNUS$1.62BUS$1.71Bn/a4.0×34.2×4.2×−5.4%0.4×n/a
Median of the othersUS$1.87BUS$1.74B56.2×6.7×34.2×4.0×5.1%0.1×1.68

Forecasts

2 strong buy · 1 buy · 3 hold · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
39.40 USD · Analysts' mean
EPS, year to Sep 2027
0.48 · 4 analysts
Revenue, year to Sep 2027
641.9M · 5 analysts

Team and board

Officers

OfficerRole
Martin Madausinterim President and CEO
Erica J. McLaughlinExecutive Vice President, CFO and Head of Corporate Strategy
Trey MartinPresident of its Multiomics business
Maria Isabel CuartasManagerInvestor Relations

Board

DirectorRole
Frank E. CasalBoard Chair
Erica J. McLaughlinExecutive Vice President, CFO and Head of Corporate Strategy
Martin Madausinterim President and CEO
Quentin G. KoffeyDirector
Robyn C. DavisDirector
Tina S. NovaDirector
William L. CornogDirector

Events

Calls

CallWhenStatus
Azenta (NASDAQ:AZTA) Q4 2026 Earnings CallWed, Nov 11, 2026 · 8:30 AM ETReplay
Azenta (NASDAQ:AZTA) Q3 2026 Earnings CallWed, Aug 05, 2026 · 8:30 AM ETReplay
Azenta (NASDAQ:AZTA) Q2 2026 Earnings CallWed, May 06, 2026 · 8:30 AM ETReplay
Azenta (NASDAQ:AZTA) Q1 2026 Earnings CallWed, Feb 04, 2026 · 8:30 AM ETReplay
Azenta (NASDAQ:AZTA) Q4 2025 Earnings CallFri, Nov 21, 2025 · 8:30 AM ETReplay
Azenta (NASDAQ:AZTA) Q3 2025 Earnings CallTue, Aug 05, 2025 · 8:30 AM ETReplay
Azenta (NASDAQ:AZTA) Q2 2025 Earnings CallWed, May 07, 2025 · 8:30 AM ETReplay
Azenta (NASDAQ:AZTA) Q1 2025 Earnings CallWed, Feb 05, 2025 · 8:30 AM ETReplay
Azenta (NASDAQ:AZTA) Q4 2024 Earnings CallTue, Nov 12, 2024 · 4:30 PM ETReplay
Azenta (NASDAQ:AZTA) Q3 2024 Earnings CallTue, Aug 06, 2024 · 4:30 PM ETReplay
All 20 calls
CallWhenStatus
Azenta (NASDAQ:AZTA) Q2 2024 Earnings CallWed, May 08, 2024 · 4:30 PM ETReplay
Azenta (NASDAQ:AZTA) Q1 2024 Earnings CallWed, Feb 07, 2024 · 4:30 PM ETReplay
Azenta (NASDAQ:AZTA) Q4 2023 Earnings CallMon, Nov 13, 2023 · 4:30 PM ETReplay
Azenta (NASDAQ:AZTA) Q3 2023 Earnings CallTue, Aug 08, 2023 · 4:30 PM ETReplay
Azenta (NASDAQ:AZTA) Q2 2023 Earnings CallTue, May 09, 2023 · 4:30 PM ETReplay
Azenta (NASDAQ:AZTA) Q1 2023 Earnings CallWed, Feb 08, 2023 · 4:30 PM ETReplay
Azenta (NASDAQ:AZTA) Q4 2022 Earnings CallMon, Nov 14, 2022 · 4:30 PM ETReplay
Azenta (NASDAQ:AZTA) Q3 2022 Earnings CallTue, Aug 09, 2022 · 4:30 PM ETReplay
Azenta (NASDAQ:AZTA) Q2 2022 Earnings CallMon, May 09, 2022 · 4:30 PM ETReplay
Azenta (NASDAQ:AZTA) Q1 2022 Earnings CallTue, Feb 08, 2022 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q4 2026Nov 10, 2026 · After close+20.8%
Q3 2026Aug 4, 2026 · After close+5.6%
Q2 2026May 5, 2026 · After close−25.3%
Q1 2026Feb 4, 2026 · Before open−22.8%
Q4 2025Nov 11, 2025 · Before open+1.3%
Q3 2025Aug 5, 2025 · Before open−17.0%
Q2 2025May 7, 2025 · Before open−0.6%
Q1 2025Feb 5, 2025 · Before open+3.4%
Q4 2024Nov 12, 2024 · After close−3.2%
Q3 2024Aug 6, 2024 · After close−8.9%
All 20 quarters
QuarterResultsShare move
Q2 2024May 8, 2024 · After close−2.9%
Q1 2024Feb 7, 2024 · After close−1.6%
Q4 2023Nov 13, 2023 · After close+13.9%
Q3 2023Aug 8, 2023 · After close+20.3%
Q2 2023May 9, 2023 · After close−18.9%
Q1 2023Feb 8, 2023 · After close−18.3%
Q4 2022Nov 14, 2022 · After close+21.8%
Q3 2022Aug 9, 2022 · After close−3.0%
Q2 2022May 9, 2022 · After close+5.6%
Q1 2022Feb 8, 2022 · After close+3.8%

Open Events

Decks

DeckKindSlidesDate
Q4 2026 Earnings PresentationEarnings14 slidesNov 11, 2026
Q4 2026 Earnings PresentationEarnings14 slidesNov 11, 2026
Q3 2026 Earnings PresentationEarnings13 slidesAug 5, 2026
Q2 2026 Earnings PresentationEarnings13 slidesMay 6, 2026
Q1 2026 Earnings PresentationEarnings13 slidesFeb 4, 2026
Investor Day (December 2025)Investor day67 slidesDec 10, 2025
Investor Day (December 2025)Investor day62 slidesDec 10, 2025
Q4 2025 Earnings PresentationEarnings14 slidesNov 21, 2025
Q3 2025 Earnings PresentationEarnings13 slidesAug 5, 2025
Q2 2025 Earnings PresentationEarnings13 slidesMay 7, 2025
Show 50 decks
DeckKindSlidesDate
Q1 2025 Earnings PresentationEarnings13 slidesFeb 5, 2025
Q4 2024 Earnings PresentationEarnings14 slidesNov 12, 2024
Q3 2024 Earnings PresentationEarnings14 slidesAug 6, 2024
Q2 2024 Earnings PresentationEarnings15 slidesMay 8, 2024
Investor Day (March 2024)Investor day66 slidesMar 14, 2024
Q1 2024 Earnings PresentationEarnings15 slidesFeb 7, 2024
26th Annual Needham Growth Conference 2024Conference25 slidesJan 18, 2024
42nd Annual J.P. Morgan Healthcare Conference (January 2024)Conference27 slidesJan 11, 2024
Q4 2023 Earnings PresentationEarnings24 slidesNov 13, 2023
Morgan Stanley 21st Annual Global Healthcare Conference (September 2023)Conference32 slidesSep 13, 2023
Baird 2023 Global Healthcare ConferenceConference32 slidesSep 12, 2023
UBS MedTech, Tools and Genomics Summit 2023Conference45 slidesAug 15, 2023
Q3 2023 Earnings PresentationEarnings19 slidesAug 8, 2023
Jefferies Healthcare Conference 2023Conference31 slidesJun 8, 2023
Q2 2023 Earnings PresentationEarnings19 slidesMay 9, 2023
22nd Annual Needham Virtual Healthcare Conference 2023Conference21 slidesApr 18, 2023
Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum 2023Conference23 slidesMar 21, 2023
Q1 FY2023 Earnings PresentationEarnings14 slidesFeb 8, 2023
Q1 2023 Earnings PresentationEarnings14 slidesFeb 8, 2023
Brooks Automation — Investor Day (November 2021)Investor day28 slidesNov 18, 2021
Brooks Automation — Merger or Acquisition (September 2021)Merger or acquisition11 slidesSep 21, 2021
Brooks Automation — Investor Presentation (May 2014)Investor deck39 slidesMay 20, 2014
Brooks Automation — Q1 FY2012 Earnings PresentationEarnings14 slidesFeb 9, 2012
Brooks Automation — Q4 FY2011 Earnings PresentationEarnings17 slidesNov 10, 2011
Brooks Automation — Q3 2011 Earnings PresentationEarnings18 slidesAug 4, 2011
Brooks Automation — Q2 FY2011 Earnings PresentationEarnings17 slidesMay 5, 2011
Brooks Automation — Q1 FY2011 Earnings PresentationEarnings15 slidesFeb 4, 2011
Brooks Automation — Q4 2010 Earnings PresentationEarnings18 slidesNov 10, 2010
Brooks Automation — Q3 FY2010 Earnings PresentationEarnings14 slidesAug 5, 2010
Brooks Automation — Q2 FY2010 Earnings PresentationEarnings14 slidesMay 6, 2010
Brooks Automation — Q1 FY2010 Earnings PresentationEarnings14 slidesFeb 5, 2010
Brooks Automation — Q4 2009 Earnings PresentationEarnings14 slidesNov 12, 2009
Brooks Automation — Q3 2009 Earnings PresentationEarnings15 slidesAug 6, 2009
Brooks Automation — Q2 FY2009 Earnings PresentationEarnings21 slidesMay 7, 2009
Brooks Automation — Q1 FY2009 Earnings PresentationEarnings13 slidesFeb 9, 2009
Brooks Automation — Q4 FY2008 Earnings PresentationEarnings12 slidesNov 14, 2008
Brooks Automation — Q3 FY2008 Earnings PresentationEarnings10 slidesAug 8, 2008
Brooks Automation — Q2 FY2008 Earnings PresentationEarnings10 slidesMay 9, 2008
Brooks Automation — Q1 FY2008 Earnings PresentationEarnings9 slidesFeb 12, 2008
Helix Technology — Merger or Acquisition (July 2005)Merger or acquisition21 slidesJul 14, 2005

This page holds 50 of 52 decks. Open Decks

Open Decks

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue621.7M593.8M573.4M551.5M555.5M513.7M388.5M334.2M631.6M527.5M
Cost of revenue346.7M323.5M318.8M312.3M299.9M269.9M216.4M199.6M385.5M425.5M
Gross profit275.0M270.3M254.6M239.2M255.6M243.8M172.1M134.6M246.1M198.9M
Research and development37.9M30.4M31.5M32.1M27.5M22.4M17.8M17.3M46.9M39.9M
Selling, general and administrative257.5M261.6M263.0M263.7M251.5M252.1M190.3M163.3M167.0M141.5M
Operating income-174.7M-26.8M-51.3M-61.2M-24.7M-31.1M-36.6M-47.4M31.4M14.3M
Depreciation and amortization56.5M61.2M90.7M85.6M53.7M65.3M65.5M54.5M37.4M28.1M
EBITDA-118.2M34.4M39.5M24.3M29.0M34.2M28.9M7.02M68.8M42.5M
Interest expense478.0K4.59M2.04M2.94M22.3M9.52M408.0K
Income before tax-151.0M-7.14M-19.1M-20.0M-9.94M-49.0M-40.3M-84.0M20.5M14.5M
Income tax6.86M-31.6M5.24M-12.0M1.35M-20.1M-13.9M-22.8M-47.3M3.38M
Net income-167.0M-55.8M-164.9M-14.6M2.13B110.7M64.9M437.4M116.6M62.6M
Earnings per share, basic-3.70-1.22-3.10-0.2228.481.490.886.081.650.90
Earnings per share, diluted-3.70-1.22-3.10-0.2228.481.490.886.041.640.89

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents193.8M279.8M280.0M649.5M658.3M227.4M250.6M256.6M197.7M101.6M
Short-term investments138.9M61.1M151.2M338.9M911.8M81.0K51.0K34.1M46.3M28.0K
Receivables143.4M142.2M154.2M156.5M163.8M119.9M94.8M165.6M125.2M93.5M
Inventory77.1M75.0M71.3M128.2M85.5M60.4M37.1M99.4M97.0M73.4M
Current assets623.5M708.3M833.0M1.42B2.46B777.4M649.5M647.1M564.1M351.8M
Property, plant and equipment272.3M154.5M180.4M112.1M100.7M60.0M57.0M
Goodwill546.3M702.4M691.4M675.4M513.6M469.4M453.2M440.8M255.9M207.2M
Total assets1.71B2.06B2.10B2.89B3.72B1.82B1.56B1.52B1.10B766.6M
Accounts payable55.2M37.7M33.3M35.8M38.7M42.4M25.7M58.9M44.7M49.1M
Current liabilities233.1M237.7M206.1M210.9M230.5M345.1M211.1M272.3M164.6M146.8M
Long-term debt49.7M49.6M50.3M194.1M
Total debt111.2M70.7M60.4M49.2M49.7M50.4M51.1M196.1M
Total liabilities311.2M332.6M332.4M351.2M352.7M494.2M345.7M377.0M377.4M159.0M
Shareholders' equity1.40B1.73B1.77B2.53B3.36B1.33B1.21B1.14B717.8M607.6M
Shares outstanding41.8M45.9M45.6M57.8M75.0M74.3M73.8M72.3M70.7M69.8M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations57.5M72.2M49.7M5.83M-466.0M149.9M37.9M90.9M74.0M96.2M
Capital spending-30.1M-33.9M-37.4M-39.4M-73.4M-52.8M-39.9M-23.9M-12.8M-12.7M
Free cash flow27.4M38.3M12.4M-33.6M-539.5M97.1M-2.06M67.0M61.2M83.5M
Cash from investing-33.8M-90.5M224.7M431.4M1.47B-146.3M-22.7M211.3M-148.5M-54.2M
Cash from financing-119.5M-9.59M-659.2M-840.5M-62.8M-25.9M-27.0M-191.2M170.3M-25.9M
Dividends paid00-7.49M-29.7M-29.5M-28.9M-28.3M-27.9M
Share buybacks-118.3M0-661.7M-838.5M0828.0K828.0K686.4M197.6M
Change in cash-98.4M-24.3M-363.1M-357.3M756.0M-17.2M-2.65M107.5M96.1M16.5M

Open Financials

Filings

FilingDateTypeFiled with
10-K · Annual reportNov 19, 2026Annual reportSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
8-K · Current reportNov 10, 2026ResultsSEC
8-K · Current reportOct 30, 2026Material contractSEC
4 · Change in ownershipOct 23, 2026Insider tradeSEC
8-K · Current reportOct 7, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 23, 2026Insider tradeSEC
8-K · Current reportSep 17, 2026Management or board changeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
3 · Initial statement of ownershipSep 9, 2026Insider tradeSEC
8-K · Current reportSep 4, 2026Current reportSEC
8-K · Current reportAug 24, 2026Management or board changeSEC
4 · Change in ownershipAug 11, 2026Insider tradeSEC
8-K · Current reportAug 10, 2026Management or board changeSEC
10-Q · Quarterly reportAug 6, 2026Quarterly reportSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
8-K · Current reportAug 4, 2026ResultsSEC
8-K · Current reportJul 8, 2026Acquisition or disposalSEC
SD · Specialized disclosureMay 26, 2026ESG reportSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
4 · Change in ownershipMay 12, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMay 8, 2026Offer documentSEC
10-Q · Quarterly reportMay 8, 2026Quarterly reportSEC
8-K · Current reportMay 5, 2026ResultsSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeApr 28, 2026Big-stake noticeSEC
3 · Initial statement of ownershipApr 16, 2026Insider tradeSEC
8-K · Current reportApr 7, 2026Management or board changeSEC
8-K · Current reportApr 2, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
8-K · Current reportMar 4, 2026Material contractSEC
4/A · Change in ownership, amendedFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
10-Q · Quarterly reportFeb 5, 2026Quarterly reportSEC
8-K · Current reportFeb 4, 2026ResultsSEC
8-K · Current reportJan 30, 2026Management or board changeSEC
8-K · Current reportJan 29, 2026Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 21, 2026Big-stake noticeSEC
8-K · Current reportDec 29, 2025Material contractSEC
DEFR14ADec 19, 2025Meeting noticeSEC
ARS · Annual report to shareholdersDec 19, 2025Annual reportSEC
DEFA14A · Additional proxy materialDec 18, 2025Meeting noticeSEC
DEF 14A · Proxy statementDec 18, 2025Meeting noticeSEC
8-K · Current reportDec 10, 2025Current reportSEC
10-K · Annual reportDec 4, 2025Annual reportSEC
4/A · Change in ownership, amendedDec 3, 2025Insider tradeSEC
NT 10-K · Late filing noticeDec 2, 2025Explanation requestSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 25, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 25, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 25, 2025Insider tradeSEC
8-K · Current reportNov 21, 2025ResultsSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 14, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 14, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 14, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 14, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 14, 2025Insider tradeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
10-Q · Quarterly reportAug 6, 2025Quarterly reportSEC
8-K · Current reportAug 5, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 18, 2025Big-stake noticeSEC
8-K · Current reportJul 2, 2025Management or board changeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4/A · Change in ownership, amendedJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 3, 2025Insider tradeSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
3 · Initial statement of ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
8-K · Current reportMay 16, 2025Management or board changeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
10-Q · Quarterly reportMay 9, 2025Quarterly reportSEC
8-K · Current reportMay 7, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 29, 2025Big-stake noticeSEC
8-K · Current reportApr 9, 2025Management or board changeSEC
4 · Change in ownershipFeb 13, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
10-Q · Quarterly reportFeb 10, 2025Quarterly reportSEC
8-K · Current reportFeb 5, 2025ResultsSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
3 · Initial statement of ownershipFeb 4, 2025Insider tradeSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
8-K · Current reportJan 30, 2025ResultsSEC
ARS · Annual report to shareholdersDec 17, 2024Annual reportSEC
DEFA14A · Additional proxy materialDec 17, 2024Meeting noticeSEC
DEF 14A · Proxy statementDec 17, 2024Meeting noticeSEC
4 · Change in ownershipDec 9, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedDec 6, 2024Big-stake noticeSEC
4 · Change in ownershipDec 5, 2024Insider tradeSEC
3 · Initial statement of ownershipDec 2, 2024Insider tradeSEC
10-K · Annual reportNov 26, 2024Annual reportSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
4 · Change in ownershipNov 14, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 14, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
8-K · Current reportNov 12, 2024ResultsSEC
4 · Change in ownershipNov 8, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 8, 2024Insider tradeSEC
4 · Change in ownershipNov 8, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 4, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedNov 4, 2024Big-stake noticeSEC
8-K · Current reportNov 4, 2024Material contractSEC
SC 13G · Big-stake noticeOct 31, 2024Big-stake noticeSEC
4 · Change in ownershipOct 21, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 11, 2024Insider tradeSEC
4 · Change in ownershipSep 11, 2024Insider tradeSEC
8-K · Current reportSep 4, 2024Management or board changeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
10-Q · Quarterly reportAug 6, 2024Quarterly reportSEC
8-K · Current reportAug 6, 2024ResultsSEC
4 · Change in ownershipAug 2, 2024Insider tradeSEC
4 · Change in ownershipAug 2, 2024Insider tradeSEC
144 · Notice of proposed saleAug 1, 2024Other filingsSEC
4 · Change in ownershipAug 1, 2024Insider tradeSEC
4 · Change in ownershipJul 29, 2024Insider tradeSEC
144 · Notice of proposed saleJul 25, 2024Other filingsSEC
SD · Specialized disclosureMay 30, 2024ESG reportSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
144 · Notice of proposed saleMay 20, 2024Other filingsSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 9, 2024Management or board changeSEC
8-K · Current reportMay 8, 2024ResultsSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
144 · Notice of proposed saleApr 1, 2024Other filingsSEC
8-K · Current reportMar 14, 2024Current reportSEC
4 · Change in ownershipMar 11, 2024Insider tradeSEC
144 · Notice of proposed saleMar 8, 2024Other filingsSEC
144 · Notice of proposed saleMar 7, 2024Other filingsSEC
144 · Notice of proposed saleFeb 14, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
4 · Change in ownershipFeb 13, 2024Insider tradeSEC
4 · Change in ownershipFeb 13, 2024Insider tradeSEC
4 · Change in ownershipFeb 13, 2024Insider tradeSEC
4 · Change in ownershipFeb 13, 2024Insider tradeSEC
4 · Change in ownershipFeb 13, 2024Insider tradeSEC
4 · Change in ownershipFeb 13, 2024Insider tradeSEC
4 · Change in ownershipFeb 13, 2024Insider tradeSEC
4 · Change in ownershipFeb 13, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
10-Q · Quarterly reportFeb 8, 2024Quarterly reportSEC
144 · Notice of proposed saleFeb 8, 2024Other filingsSEC
8-K · Current reportFeb 7, 2024ResultsSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
3 · Initial statement of ownershipFeb 2, 2024Insider tradeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
3 · Initial statement of ownershipFeb 2, 2024Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Azenta, Inc.’s releases

Common shares
43,808,393
Fully diluted
43,808,393

Fully diluted

LineShares
Common shares43,808,393

Share count over time

CountShares
Nov 22, 202643,808,393

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
BlackRock7.02MUS$245MSep 30, 2026
Politan Capital Management LP4.62MUS$161MSep 30, 2026
Vanguard4.49MUS$157MSep 30, 2026
State Street1.78MUS$62.2MSep 30, 2026
Dimensional1.2MUS$41.8MSep 30, 2026
Morgan Stanley1.15MUS$40MSep 30, 2026
D. E. Shaw & Co., Inc.1.13MUS$39.5MSep 30, 2026
Geode Capital1.11MUS$38.6MSep 30, 2026
Neuberger Berman Group LLC1.01MUS$35.1MSep 30, 2026
GW&K Investment Management, LLC993KUS$34.6MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Victory Capital797KUS$27.8MSep 30, 2026
Ameriprise784KUS$27.4MSep 30, 2026
Snyder Capital Management L P744KUS$25.9MSep 30, 2026
Royce & Associates LP709KUS$24.7MSep 30, 2026
Jupiter Asset Management LTD657KUS$22.9MSep 30, 2026
American Capital Management Inc656KUS$22.9MSep 30, 2026
Systematic Financial Management LP642KUS$22.4MSep 30, 2026
Schwab612KUS$21.4MSep 30, 2026
Allspring Global Investments Holdings, LLC587KUS$20.2MSep 30, 2026
Citadel579KUS$20.2MSep 30, 2026
Nuveen571KUS$19.9MSep 30, 2026
Algert Global LLC565KUS$19.7MSep 30, 2026
Silvercrest Asset Management Group LLC528KUS$18.4MSep 30, 2026
American Century500KUS$17.4MSep 30, 2026
Goldman Sachs500KUS$17.4MSep 30, 2026
Quantinno Capital Management LP488KUS$17MSep 30, 2026
Man Group plc482KUS$16.8MSep 30, 2026
Bank of America476KUS$16.6MSep 30, 2026
Sun Life475KUS$16.6MSep 30, 2026
Northern Trust460KUS$16MSep 30, 2026
BNP Paribas403KUS$14.1MSep 30, 2026
Tudor Investment Corp Et Al403KUS$14MSep 30, 2026
Arrowstreet Capital, Limited Partnership386KUS$13.5MSep 30, 2026
JPMorgan379KUS$13.1MSep 30, 2026
Millennium379KUS$13.2MSep 30, 2026
UBS374KUS$13MSep 30, 2026
Renaissance Technologies289KUS$10.1MSep 30, 2026
Marshall Wace, LLP276KUS$9.63MSep 30, 2026
Edgestream Partners, L.P.272KUS$9.49MSep 30, 2026
BNY260KUS$9.07MSep 30, 2026
AQR Capital Management LLC255KUS$8.8MSep 30, 2026
Federated Hermes, Inc.236KUS$8.22MSep 30, 2026
Schroders229KUS$7.87MSep 30, 2026
Nordea Investment Management AB206KUS$7.18MSep 30, 2026
Rock Springs Capital Management LP203KUS$7.07MSep 30, 2026
Invesco196KUS$6.85MSep 30, 2026
Principal189KUS$6.58MSep 30, 2026
Caxton Associates LLP180KUS$6.28MSep 30, 2026
John G Ullman & Associates Inc154KUS$5.37MSep 30, 2026
Franklin Templeton142KUS$5.57MSep 30, 2026

This page holds 50 of 262 holders. Open Shareholders

Funds

HolderSharesValueAs of
iShares Core S&P Small-Cap ETF2.47MUS$63.1MJun 30, 2026
Vanguard Total Stock Market Index Fund1.32MUS$33.7MJun 30, 2026
iShares Russell 2000 ETF1.1MUS$28MJun 30, 2026
Vanguard Small-Cap Index Fund950KUS$24.3MJun 30, 2026
Vanguard Small-Cap Value Index Fund603KUS$15.4MJun 30, 2026
MFS New Discovery Fund557KUS$12.7MMay 31, 2026
Allspring Special Small Cap Value Fund520KUS$13.3MJun 30, 2026
MFS New Discovery Value Fund504KUS$11.5MMay 31, 2026
Columbia Small Cap Value Discovery Fund486KUS$13.7MJul 31, 2026
Tarkio Fund480KUS$11MMay 31, 2026
Show 50 holders
HolderSharesValueAs of
Vanguard Extended Market Index Fund471KUS$12MJun 30, 2026
Bridge Builder Small/Mid Cap Value Fund463KUS$11.8MJun 30, 2026
Fidelity Small Cap Index Fund460KUS$12.9MJul 31, 2026
iShares Russell 2000 Value ETF394KUS$10.1MJun 30, 2026
U.S. Small Cap Value Portfolio381KUS$10.7MJul 31, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF376KUS$9.59MJun 30, 2026
Nuveen Quant Small Cap Equity Fund366KUS$10.3MJul 31, 2026
Strategic Advisers U.S. Total Stock Fund319KUS$7.31MMay 31, 2026
Vanguard Tax-Managed Small-Cap Fund311KUS$7.94MJun 30, 2026
Allspring Common Stock Fund294KUS$7.5MJun 30, 2026
Royce Small-Cap Opportunity Fund272KUS$6.94MJun 30, 2026
Neuberger Intrinsic Value Fund264KUS$6.05MMay 31, 2026
Victory Integrity Small-Cap Value Fund249KUS$6.34MJun 30, 2026
iShares S&P Small-Cap 600 Growth ETF222KUS$5.67MJun 30, 2026
Fidelity Extended Market Index Fund216KUS$4.95MMay 31, 2026
Vanguard Russell 2000 Index Fund209KUS$4.79MMay 31, 2026
Schwab U.S. Small-Cap ETF195KUS$4.46MMay 31, 2026
Dimensional US Small Cap Value ETF181KUS$5.09MJul 31, 2026
AMG GW&K Small Cap Core Fund171KUS$4.37MJun 30, 2026
MFS New Discovery Series170KUS$4.33MJun 30, 2026
Federated Hermes MDT Small Cap Core Fund167KUS$4.71MJul 31, 2026
BlackRock Advantage Small Cap Core Fund154KUS$3.53MMay 29, 2026
Vanguard S&P Small-Cap 600 Index Fund143KUS$3.26MMay 31, 2026
iShares S&P Small-Cap 600 Value ETF142KUS$3.61MJun 30, 2026
VictoryShares US Small Mid Cap Value Momentum ETF140KUS$3.57MJun 30, 2026
Brighthouse Small Cap Value Portfolio136KUS$3.46MJun 30, 2026
State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF132KUS$3.36MJun 30, 2026
Schwab Fundamental U.S. Small Company ETF126KUS$2.89MMay 31, 2026
Vanguard Health Care Index Fund125KUS$2.86MMay 31, 2026
Dimensional U.S. Core Equity 2 ETF115KUS$3.22MJul 31, 2026
Dimensional U.S. Small Cap ETF106KUS$2.97MJul 31, 2026
Schwab Small-Cap Index Fund102KUS$2.88MJul 31, 2026
Invesco RAFI US 1500 Small-Mid ETF95,968US$2.7MJul 31, 2026
State Street(R) SPDR(R) S & P 600(TM) Small Cap Value ETF90,852US$2.32MJun 30, 2026
Columbia Variable Portfolio - Small Cap Value Discovery Fund87,955US$2.24MJun 30, 2026
Royce Micro-Cap Fund84,868US$2.17MJun 30, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF84,086US$2.15MJun 30, 2026
Master Small Cap Index Series78,619US$2.01MJun 30, 2026
Fidelity Total Market Index Fund77,688US$1.78MMay 31, 2026
Column Small Cap Select Fund72,211US$1.65MMay 31, 2026

This page holds 50 of 265 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Starr Ephraim
Officer: SVP, Gen Counsel & Secretary
Buy335USD 24.17US$8,097Jul 31, 2026
Cornog William L
Director
Buy10,000USD 16.38US$164KMay 18, 2026

Big stakes

StakeStakeSharesDateFiling
Vanguard Portfolio Management LLC5.35%2.47MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Tina Susan Nova
Other companies: Aurinia Pharmaceuticals Inc (Director · Since at least May 15, 2025); Exagen Inc. (Director · Since at least Sep 18, 2019); CapForce Inc. (Director · Apr 24, 2017 – Sep 2, 2019 · Past); Veracyte, Inc. (President, CLIA U.S. · Nov 12, 2015 – Mar 3, 2022 · Past); NanoString Technologies Inc (Director · Apr 29, 2014 – Apr 29, 2014 · Past); DMK Pharmaceuticals Corporation (Director · Feb 10, 2011 – Oct 16, 2013 · Past); Genoptix Inc (President and CEO, Director · Oct 29, 2007 – Mar 7, 2011 · Past); Cypress Bioscience Inc (Director · Apr 26, 2007 – Jan 4, 2010 · Past); Arena Pharmaceuticals Inc (Director · Jul 28, 2006 – Mar 11, 2022 · Past)
Director · Since at least Feb 3, 2023
Ellen M. Zane
Other companies: GMR Solutions Inc. (Director · Since at least Jul 1, 2026); Synchrony Financial (Director · Since at least Feb 1, 2019); Boston Scientific Corporation (Board of Directors · Since at least Apr 15, 2016); Haemonetics Corporation (Chair · Since at least Jul 27, 2012); Press Ganey Holdings Inc (Director · May 20, 2015 – Oct 21, 2016 · Past); Lincare Holdings Inc (Director · Nov 1, 2010 – Aug 13, 2012 · Past); PAREXEL International Corp (Director · Jul 20, 2006 – Sep 29, 2017 · Past)
Director · May 9, 2012 – Aug 8, 2023 · Past
Didier Hirsch
Other companies: Sophia Genetics SA (Board Member · Since at least Mar 18, 2026); Knowles Corporation (Director · Dec 18, 2014 – Apr 29, 2025 · Past); Logitech International S.A. (Director · Sep 5, 2012 – Sep 8, 2021 · Past); International Rectifier Corp (Director · Mar 26, 2012 – Jan 13, 2015 · Past); Agilent Technologies, Inc. (Sr. VP and CFO · Nov 16, 2011 – Dec 7, 2017 · Past)
Director · Jan 30, 2024 – Nov 18, 2024 · Past
Amin J Khoury
Other companies: Molekule Group Inc. (Director · Nov 23, 2021 – Apr 18, 2023 · Past); KLX Energy Services Holdings, Inc. (Director · Aug 24, 2018 – Jun 11, 2020 · Past); KLX Inc (Chairman & Chief Exec. Officer, Director · Nov 26, 2014 – Oct 9, 2018 · Past); B/E Aerospace Inc (Executive Chairman, Director · Mar 24, 2006 – Apr 13, 2017 · Past)
Director · Oct 26, 2005 – Apr 12, 2006 · Past
A Clinton Allen
Other companies: Steinway Musical Instruments Inc (Director · Mar 30, 2007 – Sep 4, 2009 · Past); Collectors Universe Inc (Director · Dec 29, 2006 – Dec 4, 2018 · Past); LKQ Corporation (Director · Oct 2, 2006 – Mar 16, 2020 · Past)
Director · Mar 23, 2006 – Sep 25, 2020 · Past
Dorothy Puhy
Other companies: MiMedx Group, Inc (Director · Since at least Mar 1, 2024); ABIOMED Inc (Director · Jul 1, 2009 – Dec 22, 2022 · Past); Eaton Vance Corp (Director · Oct 31, 2008 – Feb 12, 2021 · Past)
Director · Feb 13, 2023 – Feb 13, 2023 · Past
Michael Rosenblatt
Other companies: Axcella Health Inc (Director · May 19, 2022 – May 19, 2022 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Merck & Company, Inc. (Exec V-P & Chief Med Officer · Dec 16, 2009 – May 10, 2016 · Past)
Director · Sep 4, 2018 – Feb 12, 2024 · Past
William L. Cornog
Other companies: LiveWire Group, Inc. (Director · Since at least Sep 26, 2022); BrightView Holdings, Inc. (Director · Since at least May 9, 2022); Laureate Education, Inc. (Director · May 26, 2021 – May 25, 2022 · Past)
Director · Since at least Nov 4, 2024
Herman V. Cueto
Other companies: BETA Technologies, Inc. (Chief Financial Officer · Since at least Nov 3, 2025); Dentsply Sirona Inc. (Interim Chief Financial Officer · Dec 2, 2024 – Nov 4, 2026 · Past)
EVP, Chief Financial Officer · Oct 16, 2023 – Nov 19, 2024 · Past
Kirk P Pond
Other companies: Sensata Technologies Holding plc (Director · Mar 9, 2011 – Jun 5, 2018 · Past); WEX Inc. (Director · May 15, 2009 – May 11, 2018 · Past)
Director · Feb 11, 2009 – Dec 20, 2019 · Past
All 48 people
PersonSeat
Krishna Palepu
Other companies: Allegro MicroSystems, Inc. (Baker Foundation Professor of Business Administration, and Senior Associate Dean, Business in Global Society, at the Harvard Business School · Since at least Jan 31, 2025); Polymedica Corp (Director · Jun 29, 2006 – Oct 31, 2007 · Past)
Director · Mar 23, 2006 – Feb 13, 2023 · Past
Mark S Wrighton
Other companies: Corning Incorporated (Director · Feb 2, 2011 – Feb 12, 2025 · Past); Cabot Corporation (Director · Jan 14, 2011 – Jan 7, 2021 · Past)
Director · Feb 10, 2011 – Feb 11, 2022 · Past
Martin Madaus
Other companies: Haemonetics Corporation (Director · Since at least Jul 24, 2026); Repligen Corporation (Chair of the Board · Since at least Jan 6, 2026)
interim President and CEO · Since Aug 24, 2026
Stephen S. Schwartz
Other companies: Onto Innovation Inc. (Director · Since at least Jul 16, 2024); Spire Inc. (Director · Feb 1, 2021 – Feb 3, 2023 · Past)
CEO, Director · Nov 13, 2020 – Nov 15, 2023 · Past
Tina Nova
Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Nov 4, 2026); Exagen Inc. (Executive Chair · Since at least Nov 4, 2026)
Director · Since at least Nov 4, 2026
Alan J Malus
Other companies: Thermo Fisher Scientific Inc (Executive Vice President · Aug 25, 2015 – Mar 10, 2016 · Past)
Director · Since at least Nov 6, 2024
Clinton M Haris
Other companies: Entegris, Inc. (SVP & President, APS Division · Since at least Jun 13, 2016)
SVP, Brooks Life Sciences · May 5, 2010 – Nov 8, 2013 · Past
Dipal Doshi
Other companies: Entrada Therapeutics, Inc. (Chief Executive Officer · Since at least Jun 27, 2022)
Director · Since at least Jan 30, 2025
Erica J. McLaughlin
Other companies: Cabot Corporation (President and Chief Executive Officer · Since at least May 15, 2018)
Executive Vice President, CFO and Head of Corporate Strategy · Since at least Apr 3, 2020
John Marotta
Other companies: Senseonics Holdings, Inc. (Director · Oct 31, 2022 – Nov 2, 2022 · Past)
President and CEO, Director · Since at least Sep 9, 2024
Quentin G. Koffey
Other companies: Masimo Corporation (Vice Chairman · Since at least Jan 21, 2025)
Director · Since at least Nov 1, 2024
Vandana Sriram
Other companies: Quanterix Corporation (Chief Financial Officer · Since at least Aug 21, 2023)
SVP Finance & Corp. Controller · Feb 1, 2022 – Jan 31, 2023 · Past
Violetta Hughes
Other companies: Repligen Corporation (Chief Accounting Officer · Since at least Sep 1, 2025)
VP, Chief Accounting Officer · Aug 31, 2023 – Feb 3, 2025 · Past
William E Martin III
Other companies: Maravai LifeSciences Holdings, Inc. (Chief Executive Officer · Sep 30, 2022 – Mar 17, 2025 · Past)
President Multiomics · Since at least Apr 6, 2026
Alfred Woollacott IIIDirector · Mar 23, 2006 – Dec 23, 2021 · Past
David Dong WangSVP & GM, SMS · Nov 10, 2023 – Dec 4, 2024 · Past
Ephraim StarrSVP, Gen Counsel & Secretary · Since at least May 15, 2025
Erik J BelloVP Chief Accounting Officer · Since at least Aug 31, 2026
Frank CasalDirector · Since at least Nov 5, 2021
Frank E. CasalBoard Chair · Since at least Aug 24, 2026
Ginger ZhouSVP and GM, Multiomics · Since at least Nov 15, 2022
Jason JosephSVP, General Counsel, Secy. · Nov 13, 2020 – Nov 19, 2024 · Past
John LilligSVP, MD, Brooks Life Sciences · Aug 2, 2011 – Jul 31, 2012 · Past
Kimberly CrowleySVP, Chief HR Officer · Aug 3, 2021 – Jan 31, 2023 · Past
Kush MirchandaniSVP, Worldwide Sales · Feb 7, 2012 – Dec 4, 2013 · Past
Lawrence Y LinEVP, CFO and Treasurer · Since at least Nov 28, 2024
Linda De JesusChief Commercial Officer, LS · Aug 3, 2021 – Jul 29, 2022 · Past
Lindon G RobertsonEVP & Chief Financial Officer · Nov 6, 2017 – Nov 15, 2023 · Past
Maria Isabel CuartasManagerInvestor Relations · Since at least Apr 7, 2026
Marvin G SchorrDirector · Feb 11, 2009 – Feb 10, 2011 · Past
Mitchell CoyneSVP and GM, Life Sciences Proj · Nov 17, 2022 – Nov 17, 2022 · Past
Olga PirogovaSVP and CHRO · Since at least Nov 10, 2023
Ralf K WuellnerPresident, Global Cust Op Grp · Feb 8, 2008 – Jun 8, 2009 · Past
Robin VachaSVP, GM Life Science Products · Nov 5, 2020 – Feb 1, 2024 · Past
Robyn C. DavisDirector · Since at least Jun 28, 2019
Timothy S MathewsPrincipal Accounting Officer · May 19, 2008 – May 23, 2013 · Past
Trey MartinPresident of its Multiomics business · Since at least Apr 7, 2026
William T MontoneSVP, Human Resources · Feb 7, 2012 – Sep 27, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Azenta, Inc.